Position in SRPT
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$78,456,139
-$11,538,607 QoQ
Shares Held
4,365,951
+5.6% QoQ
Ownership
4.13%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#6
of 323 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in SRPT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026FIRST TRUST ADVISORS LP holds $2,844,450,753 across 98 Biotechnology names. SRPT ranks #14 (2.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
547,132 | $341,158,687 | |
| 2 | INCY |
Incyte Corp
|
1,587,996 | $180,015,226 | |
| 3 | CORT |
Corcept Therapeutics Inc
|
1,829,545 | $159,078,937 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
289,179 | $143,643,884 | |
| 5 | EXEL |
Exelixis, Inc.
|
2,543,353 | $138,383,836 | |
| 6 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
421,534 | $126,894,380 | |
| 7 | KRYS |
Krystal Biotech, Inc.
|
324,900 | $120,755,583 | |
| 8 | AXSM |
Axsome Therapeutics, Inc.
|
482,061 | $117,994,070 |
All Filings in SRPT
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $78,456,139 | 4,365,951 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $89,994,746 | 4,135,788 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $42,880,257 | 1,992,577 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $37,379,579 | 1,939,781 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $10,731,293 | 627,561 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $25,155,929 | 394,170 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $37,909,938 | 311,785 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $58,063,359 | 464,916 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $16,102,728 | 101,916 | Shares | Sole | 2024-08-13 | |
| 2023-12-31 | $41,691,510 | 432,350 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $52,242,668 | 430,974 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $69,208,558 | 604,336 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $95,049,221 | 689,612 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $91,735,642 | 707,946 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $101,391,930 | 917,242 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $51,744,513 | 690,295 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $67,163,513 | 859,748 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $80,959,992 | 899,056 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $85,933,155 | 929,208 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $68,236,440 | 877,752 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $66,023,965 | 885,871 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $91,453,734 | 536,417 | Shares | Sole | 2021-02-02 | |
| 2020-09-30 | $82,455,721 | 587,166 | Shares | Sole | 2020-11-05 | |
| 2020-06-30 | $107,273,232 | 669,036 | Shares | Sole | 2020-07-22 | |
| 2020-03-31 | $51,881,575 | 530,378 | Shares | Sole | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||